Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use. - Suppr | 超能文献

Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.

作者信息

Simpson G M, Frederickson E, Palmer R, Pi E, Sloane R B, White K

出版信息

Biol Psychiatry. 1985 Jun;20(6):684-7. doi: 10.1016/0006-3223(85)90105-2.

DOI:10.1016/0006-3223(85)90105-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.

Biol Psychiatry. 1985 Jun;20(6):684-7. doi: 10.1016/0006-3223(85)90105-2.

2

Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.在使用单胺氧化酶抑制剂氯吉兰和反苯环丙胺进行治疗期间，人体血浆褪黑素水平会升高，但使用司来吉兰时则不会。

Psychiatry Res. 1986 Feb;17(2):119-27. doi: 10.1016/0165-1781(86)90067-3.

3

Biochemical effects of L-deprenyl in atypical depressives.L-司来吉兰对非典型抑郁症患者的生化影响。

Biol Psychiatry. 1985 May;20(5):558-65. doi: 10.1016/0006-3223(85)90027-7.

4

L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.

Br J Psychiatry. 1983 May;142:508-11. doi: 10.1192/bjp.142.5.508.

5

Platelet serotonin response to treatment in geriatric depression.老年抑郁症患者血小板5-羟色胺对治疗的反应

Biol Psychiatry. 1989 Aug;26(4):434-6. doi: 10.1016/0006-3223(89)90064-4.

6

The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.选择性单胺氧化酶B型抑制剂l-司来吉兰在内源性和非内源性抑郁症中的相对疗效。

J Clin Psychopharmacol. 1982 Feb;2(1):54-7. doi: 10.1097/00004714-198202000-00008.

7

L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.左旋司来吉兰，一种用于内源性抑郁症的选择性单胺氧化酶B型抑制剂。

Life Sci. 1980 Mar 17;26(11):877-82. doi: 10.1016/0024-3205(80)90350-1.

8

Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy.帕金森病患者的血小板单胺氧化酶：L-司来吉兰治疗的效果

J Neural Transm Park Dis Dement Sect. 1989;1(3):189-94. doi: 10.1007/BF02248668.

9

Tranylcypromine compared with L-deprenyl in Alzheimer's disease.

J Clin Psychopharmacol. 1988 Feb;8(1):23-7.

10

Dose regimen of deprenyl (selegiline) and platelet MAO activities.司来吉兰（丙炔苯丙胺）的给药方案与血小板单胺氧化酶活性。

Acta Neurol Scand Suppl. 1983;95:87-9. doi: 10.1111/j.1600-0404.1983.tb01519.x.

引用本文的文献

1

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update.司来吉兰的临床药代动力学与药效学。最新进展。

Clin Pharmacokinet. 1997 Aug;33(2):91-102. doi: 10.2165/00003088-199733020-00002.

2

The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.L-司来吉兰对犬行为、认知功能及生物胺的影响。

Neurochem Res. 1993 Dec;18(12):1211-9. doi: 10.1007/BF00975038.